Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis.

Bryant AJ, Robinson LJ, Moore CS, Blackwell TR, Gladson S, Penner NL, Burman A, McClellan LJ, Polosukhin VV, Tanjore H, McConaha ME, Gleaves LA, Talati MA, Hemnes AR, Fessel JP, Lawson WE, Blackwell TS, West JD.

Pulm Circ. 2015 Dec;5(4):681-90. doi: 10.1086/683811.

2.

Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.

Affandi AJ, Radstake TR, Marut W.

Semin Immunopathol. 2015 Sep;37(5):475-87. doi: 10.1007/s00281-015-0506-4. Epub 2015 Jul 14.

3.
4.

Rap1 promotes endothelial mechanosensing complex formation, NO release and normal endothelial function.

Lakshmikanthan S, Zheng X, Nishijima Y, Sobczak M, Szabo A, Vasquez-Vivar J, Zhang DX, Chrzanowska-Wodnicka M.

EMBO Rep. 2015 May;16(5):628-37. doi: 10.15252/embr.201439846. Epub 2015 Mar 25.

PMID:
25807985
5.

Oestrogen receptor alpha in pulmonary hypertension.

Wright AF, Ewart MA, Mair K, Nilsen M, Dempsie Y, Loughlin L, Maclean MR.

Cardiovasc Res. 2015 May 1;106(2):206-16. doi: 10.1093/cvr/cvv106. Epub 2015 Mar 12.

6.

Microarray analysis after umbilical cord blood derived mesenchymal stem cells injection in monocrotaline-induced pulmonary artery hypertension rats.

Lee JC, Kim KC, Yang YS, Oh W, Choi SJ, Choe SY, Hong YM.

Anat Cell Biol. 2014 Dec;47(4):217-26. doi: 10.5115/acb.2014.47.4.217. Epub 2014 Dec 23.

7.

A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.

Bauer Y, Tedrow J, de Bernard S, Birker-Robaczewska M, Gibson KF, Guardela BJ, Hess P, Klenk A, Lindell KO, Poirey S, Renault B, Rey M, Weber E, Nayler O, Kaminski N.

Am J Respir Cell Mol Biol. 2015 Feb;52(2):217-31. doi: 10.1165/rcmb.2013-0310OC.

8.

Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

Rogers NM, Yao M, Sembrat J, George MP, Knupp H, Ross M, Sharifi-Sanjani M, Milosevic J, St Croix C, Rajkumar R, Frid MG, Hunter KS, Mazzaro L, Novelli EM, Stenmark KR, Gladwin MT, Ahmad F, Champion HC, Isenberg JS.

Pulm Circ. 2013 Dec;3(4):936-51. doi: 10.1086/674754.

9.

Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension.

Gore B, Izikki M, Mercier O, Dewachter L, Fadel E, Humbert M, Dartevelle P, Simonneau G, Naeije R, Lebrin F, Eddahibi S.

PLoS One. 2014 Jun 23;9(6):e100310. doi: 10.1371/journal.pone.0100310. eCollection 2014.

10.

Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension.

West JD, Austin ED, Gaskill C, Marriott S, Baskir R, Bilousova G, Jean JC, Hemnes AR, Menon S, Bloodworth NC, Fessel JP, Kropski JA, Irwin D, Ware LB, Wheeler L, Hong CC, Meyrick B, Loyd JE, Bowman AB, Ess KC, Klemm DJ, Young PP, Merryman WD, Kotton D, Majka SM.

Am J Physiol Cell Physiol. 2014 Sep 1;307(5):C415-30. doi: 10.1152/ajpcell.00057.2014. Epub 2014 May 28.

11.

Rap1b in smooth muscle and endothelium is required for maintenance of vascular tone and normal blood pressure.

Lakshmikanthan S, Zieba BJ, Ge ZD, Momotani K, Zheng X, Lund H, Artamonov MV, Maas JE, Szabo A, Zhang DX, Auchampach JA, Mattson DL, Somlyo AV, Chrzanowska-Wodnicka M.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1486-94. doi: 10.1161/ATVBAHA.114.303678. Epub 2014 May 1.

12.

Thrombosis, platelets, microparticles and PAH: more than a clot.

Lannan KL, Phipps RP, White RJ.

Drug Discov Today. 2014 Aug;19(8):1230-5. doi: 10.1016/j.drudis.2014.04.001. Epub 2014 Apr 18. Review.

13.

Sex differences in the pulmonary circulation: implications for pulmonary hypertension.

Martin YN, Pabelick CM.

Am J Physiol Heart Circ Physiol. 2014 May;306(9):H1253-64. doi: 10.1152/ajpheart.00857.2013. Epub 2014 Mar 7. Review.

14.

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.

van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, Farina GA, Stifano G, Mathes AL, Cossu M, York M, Collins C, Wenink M, Huijbens R, Hesselstrand R, Saxne T, DiMarzio M, Wuttge D, Agarwal SK, Reveille JD, Assassi S, Mayes M, Deng Y, Drenth JP, de Graaf J, den Heijer M, Kallenberg CG, Bijl M, Loof A, van den Berg WB, Joosten LA, Smith V, de Keyser F, Scorza R, Lunardi C, van Riel PL, Vonk M, van Heerde W, Meller S, Homey B, Beretta L, Roest M, Trojanowska M, Lafyatis R, Radstake TR.

N Engl J Med. 2014 Jan 30;370(5):433-43. doi: 10.1056/NEJMoa1114576. Epub 2013 Dec 18.

15.

Author's Reply.

Das M, Fessel J, West J.

Pulm Circ. 2013 Apr;3(2):447-8. No abstract available.

16.

Gender, sex hormones and pulmonary hypertension.

Austin ED, Lahm T, West J, Tofovic SP, Johansen AK, Maclean MR, Alzoubi A, Oka M.

Pulm Circ. 2013 Apr;3(2):294-314. doi: 10.4103/2045-8932.114756. Review.

17.

Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.

Mair KM, Johansen AK, Wright AF, Wallace E, MacLean MR.

Br J Pharmacol. 2014 Feb;171(3):567-79. doi: 10.1111/bph.12281. Review.

18.

Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis.

Patel NM, Kawut SM, Jelic S, Arcasoy SM, Lederer DJ, Borczuk AC.

Eur Respir J. 2013 Jun;41(6):1324-30. doi: 10.1183/09031936.00084112.

19.

Integrating molecular genetics and systems approaches to pulmonary vascular diseases.

Geraci MW.

Pulm Circ. 2013 Jan;3(1):171-5. doi: 10.4103/2045-8932.109959.

20.

Vascular histomolecular analysis by sequential endoarterial biopsy in a shunt model of pulmonary hypertension.

Rothman A, Davidson S, Wiencek RG, Evans WN, Restrepo H, Sarukhanov V, Ruoslahti E, Williams R, Mann D.

Pulm Circ. 2013 Jan;3(1):50-7. doi: 10.4103/2045-8932.109913.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk